These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 3933319

  • 1. Spectrum of antiarrhythmic response to encainide.
    Duff HJ, Roden DM, Carey EL, Wang T, Primm RK, Woosley RL.
    Am J Cardiol; 1985 Nov 15; 56(13):887-91. PubMed ID: 3933319
    [Abstract] [Full Text] [Related]

  • 2. Response to encainide of refractory ventricular tachycardia: clinical application of assays for parent drug and metabolites.
    Anderson JL, Stewart JR, Johnson TA, Lutz JR, Pitt B.
    J Cardiovasc Pharmacol; 1982 Nov 15; 4(5):812-9. PubMed ID: 6182414
    [Abstract] [Full Text] [Related]

  • 3. Treatment of frequent ventricular arrhythmia with encainide: assessment using serial ambulatory electrocardiograms, intracardiac electrophysiologic studies, treadmill exercise tests, and radionuclide cineangiographic studies.
    DiBianco R, Fletcher RD, Cohen AI, Gottdiener JS, Singh SN, Katz RJ, Bates HR, Sauerbrunn B.
    Circulation; 1982 Jun 15; 65(6):1134-47. PubMed ID: 6804110
    [Abstract] [Full Text] [Related]

  • 4. Electrophysiologic and electrocardiographic effects, efficacy and safety of encainide in malignant ventricular arrhythmias associated with coronary artery disease.
    Weintraub AR, Manolis AS, Estes NA.
    Am J Cardiol; 1990 Oct 15; 66(12):947-53. PubMed ID: 2121017
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H, Brugada P, Green M, Wehr M, Wellens HJ.
    Am J Cardiol; 1984 Sep 01; 54(6):544-9. PubMed ID: 6433688
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term efficacy of oral encainide in frequent and repetitive ventricular arrhythmias.
    Bongiorni MG, Levorato D, Arlotta C, Paperini L, Contini C.
    Eur Heart J; 1988 Jul 01; 9(7):765-76. PubMed ID: 3139413
    [Abstract] [Full Text] [Related]

  • 9. Possible contribution of encainide metabolites to the long-term antiarrhythmic efficacy of encainide.
    Winkle RA, Peters F, Kates RE, Harrison DC.
    Am J Cardiol; 1983 Apr 01; 51(7):1182-8. PubMed ID: 6404150
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathway.
    Kunze KP, Kuck KH, Schlüter M, Kuch B, Bleifeld W.
    Am J Cardiol; 1984 Aug 01; 54(3):323-9. PubMed ID: 6431796
    [Abstract] [Full Text] [Related]

  • 13. Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics.
    Roden DM, Reele SB, Higgins SB, Mayol RF, Gammans RE, Oates JA, Woosley RL.
    N Engl J Med; 1980 Apr 17; 302(16):877-82. PubMed ID: 6767186
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Flecainide and encainide.
    Furlanello F, Vergara G, Bettini R, Mosna G, Gramegna L, Disertori M.
    Eur Heart J; 1987 Mar 17; 8 Suppl A():33-40. PubMed ID: 3107989
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.